People
Rezolute, Inc., a biopharmaceutical company specializing in the development of innovative drug therapies for patients with metabolic diseases, announced the appointment of Gil Labrucherie to its Board of Directors where he will serve as Chairman of the Audit Committee.
The company has doubled its headcount to about 60 employees and doubled its square-footage in the city with the 26,000 square-foot facility.
MorphoSys AG announced that Dr. Markus Enzelberger, the company’s Chief Scientific Officer, has decided to step down as CSO and member of the company’s Management Board to explore new opportunities. Dr. Enzelberger will leave MorphoSys on February 29, 2020.
Pelican BioThermal, the global name in temperature-controlled packaging, announces the appointment of Ed Meyer, general manager for Canada sales and operations of parent company Pelican Products, Inc., to the global sales leadership role for the BioThermal division.
Pharma and biotech companies strengthen their leadership teams and boards with this week’s appointments.
A peculiarity of autoimmune diseases is that they have many genes in common, but they develop differently.
The AP report shows that in China, Mundipharma representatives are informing doctors that OxyContin is less addictive than other painkillers, which is a similar tactic the company used in the 1990s in the United States.
Peli BioThermal, the global name in temperature-controlled packaging, announces the appointment of Ed Meyer, general manager for Canada sales and operations of parent company Pelican Products, Inc., to the global sales leadership role for the BioThermal division.
Polyphor AG announced that Chairman of the Board Argeris “Jerry” Karabelas has resigned from the company for personal reasons, effective immediately.
Gut microbiome analysis experts Microba had three of their researchers – including both co-founders – named in the 2019 Highly Cited Researchers list by the Web of Science Group released yesterday.
PRESS RELEASES